(Q47685146)

4 February 2018

title

Varicella in French adolescents and adults: individual risk assessment and cost-effectiveness of routine vaccination (English)

1 reference

4 February 2018

1 reference

2

1 reference

4 February 2018

Fabrice Carrat

4

1 reference

4 February 2018

Michael Schwarzinger

object named as

Michael Schwarzinger

3

0 references

Kenneth A. Freedberg

5

object named as

Kenneth A Freedberg

1 reference

4 February 2018

Alain-Jacques Valleron

6

object named as

Alain-Jacques Valleron

1 reference

4 February 2018

7

Antoine Flahault

1 reference

4 February 2018

author name string

Thomas Hanslik

1

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 September 2003

1 reference

4 February 2018

number of pages

9

1 reference

inferred from page(s)

published in

Vaccine

1 reference

4 February 2018

volume

21

1 reference

4 February 2018

issue

25-26

1 reference

4 February 2018

page(s)

3614-3622

1 reference

4 February 2018

Shift in age in chickenpox

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

Shift in age in chickenpox

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

Review of 26 years' hospital admissions for chickenpox in North London

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

The seroepidemiology of varicella in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

Varicella mortality: trends before vaccine licensure in the United States, 1970-1994

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

Epidemiology of primary varicella and herpes zoster hospitalizations: the pre-varicella vaccine era.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

Deaths from chickenpox in England and Wales 1995-7: analysis of routine mortality data

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

Epidemiologic effects of varicella vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

Immunisation against chickenpox

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

Epidemiology of chickenpox in England and Wales, 1967-85.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

The value of varicella vaccination in healthy children: cost-benefit analysis of the situation in France

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

Cost effectiveness of vaccination strategies in adults without a history of chickenpox

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

A cost benefit analysis of routine varicella vaccination in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

Childhood vaccination against chickenpox: an analysis of benefits and costs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

Cost-effectiveness of a routine varicella vaccination program for US children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

Costs And Benefits Of Routine Varicella Vaccination In German Children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

The cost-effectiveness of varicella vaccine programs for Australia.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

The cost-effectiveness of varicella screening and vaccination in U.S. Army recruits

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

An economic analysis of varicella vaccination for health care workers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

Varicella susceptibility and vaccination strategies in young adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

Reactions of pediatricians to the recommendation for universal varicella vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

Postlicensure safety surveillance for varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

The postmarketing safety profile of varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

The susceptibility of young adult Americans to vaccine-preventable infections. A national serosurvey of US Army recruits

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

The risk of measles, mumps, and varicella among young adults: a serosurvey of US Navy and Marine Corps recruits

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900405-5

7 January 2021

10.1016/S0264-410X(03)00405-5

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018